{"doc_id": "PMC-2222968-22-Materials_and_Methods-14.txt", "sent_id": "", "tokens": ["Administration", "of", "cytokines", "and", "antibodies", "in", "vivo", "."], "sentence": "Administration of cytokines and antibodies in vivo .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2222968-22-Materials_and_Methods-14.txt", "sent_id": "S2", "tokens": ["Age", "-", "and", "gender-matched", "normal", "B6", "mice", "received", "every", "other", "day", "intraperitoneal", "(", "ip", ")", "injections", "of", "PBS", ",", "1.5", "mug", "rmIL-4", ",", "50", "mug", "anti", "-", "IL-4", "mAb", "(", "11B11", "or", "MAB404", ")", ",", "or", "a", "mixture", "of", "1.5", "mug", "rm", "IL-4", "plus", "50", "mug", "anti", "-", "IL-4", "mAb", "(", "11B11", "or", "MAB404", ")", "for", "7", "d", ".", "Thereafter", ",", "spleen", "and", "lymph", "node", "cells", "were", "analyzed", "by", "flow", "cytometry", "for", "CD3", ",", "CD4", ",", "and", "CD25", "expression", "."], "sentence": "Age - and gender-matched normal B6 mice received every other day intraperitoneal ( ip ) injections of PBS , 1.5 mug rmIL-4 , 50 mug anti - IL-4 mAb ( 11B11 or MAB404 ) , or a mixture of 1.5 mug rm IL-4 plus 50 mug anti - IL-4 mAb ( 11B11 or MAB404 ) for 7 d . Thereafter , spleen and lymph node cells were analyzed by flow cytometry for CD3 , CD4 , and CD25 expression .", "event_mentions": [{"id": "E1", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 78, "end": 78}, "arguments": [{"entity_id": "T4", "text": "CD3", "role": "Theme"}]}, {"id": "E2", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 78, "end": 78}, "arguments": [{"entity_id": "T5", "text": "CD4", "role": "Theme"}]}, {"id": "E3", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 78, "end": 78}, "arguments": [{"entity_id": "T6", "text": "CD25", "role": "Theme"}]}], "entity_mentions": [{"id": "T1", "text": "IL-4", "entity_type": "Protein", "start": 27, "end": 27}, {"id": "T2", "text": "IL-4", "entity_type": "Protein", "start": 42, "end": 42}, {"id": "T3", "text": "IL-4", "entity_type": "Protein", "start": 48, "end": 48}, {"id": "T4", "text": "CD3", "entity_type": "Protein", "start": 72, "end": 72}, {"id": "T5", "text": "CD4", "entity_type": "Protein", "start": 74, "end": 74}, {"id": "T6", "text": "CD25", "entity_type": "Protein", "start": 77, "end": 77}, {"id": "T9", "text": "expression", "entity_type": "Gene_expression", "start": 78, "end": 78}]}
{"doc_id": "PMC-2222968-22-Materials_and_Methods-14.txt", "sent_id": "S3", "tokens": ["The", "anti-mouse", "IL-4", "mAb", "MAB404", "was", "obtained", "from", "R", "&", "D", "Systems", ",", "the", "second", "anti-mouse", "IL-4", "mAb", "11B11", "was", "purchased", "from", "eBioscience", "."], "sentence": "The anti-mouse IL-4 mAb MAB404 was obtained from R & D Systems , the second anti-mouse IL-4 mAb 11B11 was purchased from eBioscience .", "event_mentions": [], "entity_mentions": [{"id": "T7", "text": "IL-4", "entity_type": "Protein", "start": 2, "end": 2}, {"id": "T8", "text": "IL-4", "entity_type": "Protein", "start": 16, "end": 16}]}
